STEFANI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 23.069
EU - Europa 13.008
AS - Asia 11.485
SA - Sud America 2.126
AF - Africa 1.227
Continente sconosciuto - Info sul continente non disponibili 843
OC - Oceania 25
AN - Antartide 2
Totale 51.785
Nazione #
US - Stati Uniti d'America 22.078
SG - Singapore 5.968
RU - Federazione Russa 3.442
IT - Italia 3.407
CN - Cina 3.061
IE - Irlanda 1.806
BR - Brasile 1.788
UA - Ucraina 1.593
VN - Vietnam 863
CA - Canada 736
CI - Costa d'Avorio 628
FR - Francia 612
DE - Germania 580
SE - Svezia 409
KR - Corea 307
GB - Regno Unito 301
NG - Nigeria 242
IN - India 241
BD - Bangladesh 198
FI - Finlandia 195
AR - Argentina 121
MX - Messico 118
ES - Italia 102
SN - Senegal 101
IQ - Iraq 98
PL - Polonia 95
HK - Hong Kong 93
NL - Olanda 91
ZA - Sudafrica 83
TR - Turchia 82
JP - Giappone 81
BE - Belgio 80
ID - Indonesia 70
PK - Pakistan 70
CH - Svizzera 58
EC - Ecuador 57
UZ - Uzbekistan 55
AT - Austria 53
VE - Venezuela 46
JM - Giamaica 37
CO - Colombia 36
GR - Grecia 34
BJ - Benin 31
AE - Emirati Arabi Uniti 30
MA - Marocco 30
IR - Iran 27
JO - Giordania 27
KE - Kenya 27
LB - Libano 26
SA - Arabia Saudita 25
UY - Uruguay 23
DZ - Algeria 22
IL - Israele 21
KZ - Kazakistan 21
MY - Malesia 21
AU - Australia 20
RO - Romania 20
EG - Egitto 19
CR - Costa Rica 18
LT - Lituania 17
NO - Norvegia 17
PY - Paraguay 17
CL - Cile 16
NP - Nepal 16
TN - Tunisia 16
HN - Honduras 15
NI - Nicaragua 14
PH - Filippine 14
CZ - Repubblica Ceca 12
EU - Europa 12
BO - Bolivia 11
PE - Perù 11
BG - Bulgaria 10
HR - Croazia 9
OM - Oman 9
PA - Panama 9
SY - Repubblica araba siriana 8
AZ - Azerbaigian 7
BB - Barbados 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
RS - Serbia 7
TT - Trinidad e Tobago 7
AO - Angola 6
BH - Bahrain 6
DK - Danimarca 6
MD - Moldavia 6
PR - Porto Rico 6
PT - Portogallo 6
AL - Albania 5
MT - Malta 5
AM - Armenia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
BS - Bahamas 3
Totale 50.888
Città #
Dallas 3.451
Singapore 3.405
Santa Clara 2.542
Dublin 1.803
San Jose 1.785
Chandler 1.644
Jacksonville 1.633
Moscow 1.358
Ashburn 1.169
Boardman 769
Catania 763
Chicago 645
Abidjan 628
Los Angeles 503
Nanjing 487
Lawrence 485
Cambridge 483
Andover 472
Lauterbourg 472
Council Bluffs 467
Hefei 454
Toronto 450
Beijing 438
Houston 434
Seoul 307
Des Moines 286
Ho Chi Minh City 285
San Mateo 248
Munich 232
New York 218
Civitanova Marche 193
Hanoi 188
São Paulo 187
Messina 185
Wilmington 179
Nanchang 155
Hebei 147
Buffalo 143
Bremen 139
Shenyang 136
Rome 131
Palermo 129
Lagos 124
Saint Petersburg 118
Jiaxing 113
Ottawa 107
Helsinki 106
Dakar 101
Changsha 97
Abuja 95
Montreal 93
Belpasso 89
Tianjin 83
Grafing 82
Hong Kong 82
Orem 82
Milan 80
Brussels 78
Tokyo 77
The Dalles 74
Seattle 70
Phoenix 67
Warsaw 67
Columbus 66
Atlanta 65
Lappeenranta 65
Brooklyn 61
Rio de Janeiro 59
London 57
Johannesburg 54
Acireale 53
Chennai 53
Denver 52
Haiphong 46
Stockholm 46
Boston 45
Mexico City 45
Amsterdam 43
San Francisco 43
Washington 40
Baghdad 39
Brolo 38
Dong Ket 38
Syracuse 38
Poplar 36
Da Nang 35
Brasília 33
Reggio Calabria 33
Belo Horizonte 32
Curitiba 32
Hangzhou 32
Cotonou 31
Falls Church 30
Naples 30
Kunming 29
Dhaka 28
Frankfurt am Main 28
Tashkent 28
Ankara 27
Manchester 27
Totale 33.650
Nome #
Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA) 384
Guida alla determinazione delle alghe del Mediterraneo. Parte I: Alghe azzurre (Cyanophyta o Cyanobacteria) 322
A Snapshot of the COL-R Acinetobacter baumannii Comparative Transcriptome by RNA-seq. 319
Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug 314
In vitro activity of levofloxacin against coagulase-positive and –negative staphylococci 310
Gut Microbiota and Cancer: From Pathogenesis to Therapy 262
Attività antibatterica di netilmicina e netilmicina/desametasone, in paragone con altri antibiotici, verso Gram-positivi e Gram-negativi isolati da infezioni oculari. 194
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 193
Bactericidal activity of Ceftobiprole combined with different antibiotics against selected gram-positive isolates 188
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 184
A multicenter study on central venous catheter-associated infections in Italy 184
A Clinical protocol for safety and colonization in human rhinopharynx by S.salivarius 24SMBc 181
Potential associations among alteration of salivary mirnas, saliva microbiome structure, and cognitive impairments in autistic children 181
Single-nucleotide polymorphism and downstream signaling associated with chronic rhinosinusitis, asthma, allergy and acetylsalicylic-acid intolerance: a narrative review 177
Ability of osteoblast invasion of rifampicin- methicillin-resistant Staphylococcus aureus isolates 177
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience 174
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy 173
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 172
Interactions of Gram-Positive Bacterial Membrane Vesicles and Hosts: Updates and Future Directions 169
Heteroaryl-Ethylenes as New Effective Agents for High Priority Gram-Positive and Gram-Negative Bacterial Clinical Isolates 166
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy 166
Streptococcus salivarius 24SMBc Genome Analysis Reveals New Biosynthetic Gene Clusters Involved in Antimicrobial Effects on Streptococcus pneumoniae and Streptococcus pyogenes 165
Different modulatory effects of four methicillin‐resistant Staphylococcus aureus clones on MG-63 osteoblast-like cells 164
Bactericidal and synergistic activity of ceftobiprole combined with different antibiotics against selected Gram-positive isolates 162
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011 162
A bioinformatic approach to microbial proteome analysis 160
Burkholderia cepacia complex in cystic fibrosis and non cystic fibrosis patients: identification of a cluster of epidemic lineages 159
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) (Liofilchem srl, Italy). 159
A clinical study comparing ofloxacin (0,3%) with tobramycin (0,3%), for th tretment of external ocular infection 158
Burden of Rifampicin- and Methicillin-Resistant Staphylococcus aureus in Italy. 158
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DELLE INFEZIONI CRONICHE DEL TRATTO RESPIRATORIO" 157
Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability 156
Agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus 156
CovidTGI: A tool to investigate the temporal genetic instability of SARS-CoV-2 variants 155
Microbiome differences in periodontal, peri-implant, and healthy sites: a cross-sectional pilot study 154
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) 153
Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011) Working group: Abate C, Allù M, Arena M, Armenia FR, Barberi I, Barraco G, Belbruno F, Bozzanca L, Bruno G, Canzeroni G, Casà C, Casuccio N, Contrino L, Cuccia M, Cavaleri G, D'Angelo R, Di Naro S, Di Stefano P, Dones P, Emma F, Falsaperla R, Ferrera G, Geraci G, Ghiraldi E, Gramaglia G, Iacono F, Incorpora, Lizzio A, Madonia S, Malato C, Marcantonio G, Margani S, Merlino F, Nicastro L, Palillo L, Pavone P, Porto A, Puglisi G, Rotondo A, Salvo V, Santagati M.C., Santangelo C, Sferrazza I, Stassi G, Tumminelli F, Varvaro A, Vitale M. 153
ACTION OF CLINDAMYCIN-PHOSPHATE IN FOREIGN-BODY INFECTIONS DUE TO STAPHYLOCOCCUS-EPIDERMIDIS IN MICE 151
The Rapid Phenotypic Susceptibility Testing in Real-Life Experience: How the MIC Values Impact on Sepsis Fast Diagnostic Workflow 149
Discriminatory Weight of SNPs in Spike SARS-CoV-2 Variants: A Technically Rapid, Unambiguous, and Bioinformatically Validated Laboratory Approach 149
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations 148
Aspetti Microbiologici e legislativi delle piscine:valutazione dell’azione batterica di due disinfettanti a base di cloro, comunemente utilizzati in piscina 148
Testing surgical face masks in an emergency context: The experience of italian laboratories during the COVID-19 pandemic crisis 147
VISA CA-MRSA Transcriptomic Adaptations Emerging Under Teicoplanin Therapy 146
Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia. 146
Attività antibatterica in vitro dell’associazione thrimethoprim/sulfadiazina 146
Oregano and Thyme Essential Oils Encapsulated in Chitosan Nanoparticles as Effective Antimicrobial Agents against Foodborne Pathogens 146
Activity of Tigecycline against well characterized multi-resistant Gram-positive strains 144
Cell-free supernatant of Lactobacillus gasseri 1A-TV shows a promising activity to eradicate carbapenem-resistant Klebsiella pneumoniae colonization 144
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion 143
Cefditoren versus community acquired respiratory pathogens: time kill studies 143
Application of bacteriotherapy in human rhinopharynx 143
Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in Enterococcus faecalis 142
Attività in vitro di tigeciclina e altri antibiotici verso Acinetobacter baumannii isolati da infezioni gravi in Italia 142
44 Oral streptococci producing bacteriocin-like inhibitory substances (BLIS) as oral probiotics against potential upper respiratory tract pathogens 142
Analysis of polycystic kidney disease with two new microsatellite markers 142
Detection of methicillin-resistant Staphylococcus aureus persistence in osteoblasts using imaging flow cytometry 142
Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis 142
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 141
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study 141
A contribute on the fosfomycin mechanism of resistance in MDR organisms 140
Antibiotico-resistenza, Genomovar Status e Distribuzione di markers di patogenicità in Burkholderia cepacia complex 140
Antipneumococcal activity of telithromycin in comparison with other drugs in relation to the presence of different resistance genes 140
Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants 140
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer 139
AF141943 - Haemophilus parainfluenzae 16S/23S long rRNA spacer region; tRNA-Ile and tRNA-Ala genes, complete sequences 139
Berberine-styrene-co-maleic acid nanomicelles: unlocking opportunities for the treatment and prevention of bacterial infections 138
Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning 138
Genomic characterization of a new biofilm-forming and adhesive st398 human-adapted mssa lineage causing septic knee arthritis following surgical reconstruction 138
Study of a melanic pigment of Proteus mirabilis 137
Evaluation of the Effects of Heteroaryl Ethylene Molecules in Combination with Antibiotics: A Preliminary Study on Control Strains 136
Change in daptomycin killing activity in MRSA clones under vancomycin challenge 135
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DI MALATTIE DEL TRATTO RESPIRATORIO" 135
Eventi avversi e trigger C12: Stroke in ospedale 135
Colonization and persistence of S.salivarius 24 SMBc in human rhinopharynx 134
Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus 133
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. 133
Staphylococcus aureus ST228 and ST239 as models for expression studies of diverse markers during osteoblast infection and persistence 133
Deciphering DAP and Glycopeptide mechanism of action-related transcriptome profiling by RNA-seq in S.aureus. 132
A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution 132
AGR DEFICIENCY AND EXPRESSION CHANGES IN REGULATORY AND CELL WALL GENES RESPONSIBLE FOR HVISA AND VISA PHENOTYPES 132
Complex Systems Biology: Structural, Functional and Pathological Genomics of the Apoptotic Machinery and Identification of Candidate Genes for Breast Adenocarcinoma, Thyroid Carcinoma and Neuroblastoma 132
BURKHOLDERIA GLADIOLI, A BIOCONTROL AGENT AGAINST GREEN AND BLU MOLD OF FRUITS 132
CRISPR-Cas system molecular organization and functionality in clinical MDR Staphylococcus epidermidis. 131
Gain-in omic signatures of colistin-resistant Acinetobacter baumannii undergoing colistin therapy. 131
Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains 131
agr-genotyping of biofilm producing Staphylococcus aureus 131
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status 131
Heteroaryl-ethylenes as new effective agents in the fight against high priority Gram-positive and Gram-negative bacterial clinical isolates 130
Infections with VIM-1 metallo beta-lactamase producing Enterobacter cloacae and their correlation with clinical outcome 130
Heteroresistance to glycopeptides in Italian methicillin-resistant Staphylococcus aureus (MRSA) isolates 130
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit 130
CHEESE MAKING USING WOODENEQUIPMENT PROMOTE BIOFILM FORMATION BY S AUREUS 129
AGR FUNCTIONALITY AND ABILITY TO FORM BIOFILM IN COL AND NRS149 STAPHYLOCOCCUS AUREUS 128
Colistin resistance onset strategies and genomic mosaicism in clinical acinetobacter baumannii lineages 128
Biofilm production and correlation with agr-allele distribution in medical-devices associated with Staphylococcus aureus 127
COLRAcinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets 127
In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci. 126
Antibacterial activity of Netilmicin and Netilmicin/Dexamethasone fixed combination against the most common ocular isolates 126
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma 126
Totale 15.763
Categoria #
all - tutte 178.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.678 0 0 31 60 537 35 503 108 373 50 95 886
2022/20235.673 538 184 111 531 548 1.014 37 881 1.419 50 264 96
2023/20242.620 146 383 111 183 113 498 58 133 34 91 484 386
2024/202510.049 150 1.391 633 461 2.240 994 446 418 845 1.003 641 827
2025/202621.434 1.337 1.090 3.885 1.414 3.354 3.872 2.746 549 946 1.177 583 481
2026/20271.483 480 947 56 0 0 0 0 0 0 0 0 0
Totale 51.785